Rocket Isotopes Competitive Advantage
Rocket Isotopes has already secured access to key resources for RLT manufacturing, getting ahead of the market
Rocket Isotopes builds on key processes and a leading science team to manufacture cutting-edge radioligand therapies
Established In-house purification process
The Rocket Isotopes team has developed an in-house semi-automated purification process that offers high-purity Tb-161.
PIONEERING Tb-161 DEVELOPMENT
The scientific team of Rocket Isotopes has been at the forefront of Tb-161 development, creating an unparalleled edge in terms of manufacturing process set-up.
In-house purification
Established an in-house semi-automated procedure to get Tb-161, with the potential of scaling up for commercial supply.
Excellent Quality
High purity of Tb-161 makes it suitable for radiolabeling at high specific activities.
while having established complete supply chain control
Rocket Isotopes is uniquely positioned to enable a reliable supply of Tb-161 to effectively enable manufacturing of radioligand therapies developed by Torpedo Pharmaceuticals
Tb-161 is a viable competitor to Lu-177, the gold standard isotope used in the most commercially successful RLT therapy to date
- FDA-approved in 2022, Pluvicto (Novartis) achieved blockbuster status 18 months post launch
- $980M sales in 2023 and $1.39B in 2024 (+42% YoY growth) with peak potential projected at over $6B annually
Tb-161 is positioned to surpass Lu-177
- Developed by scientific leaders, Terbium-161 is a radioisotope that emits both beta-minus particles and Auger and conversion electrons
- Unique properties of Tb-161 contribute to superiority over Lu-177
- In pre-clinical studies 161Tb-PSMA has demonstrated meaningful advantages over 177Lu-PSMA across all endpoints in preclinical studies
Tb-161 is the main isotope in sister company Torpedo’s flagship therapy
- The relationship between Rocket Isotopes and Torpedo provides the perfect opportunity to leverage synergies between the manufacturing and product side, while optimizing the entire supply chain